Clinical significance of differences in bioavailability of medroxyprogesterone acetate preparations

Clin Pharmacokinet. 1989 Mar;16(3):129-33. doi: 10.2165/00003088-198916030-00001.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / pharmacokinetics*
  • Antineoplastic Agents / therapeutic use
  • Biological Availability
  • Breast Neoplasms / drug therapy*
  • Drug Compounding
  • Humans
  • Medroxyprogesterone / analogs & derivatives*
  • Medroxyprogesterone / pharmacokinetics
  • Medroxyprogesterone / therapeutic use
  • Medroxyprogesterone Acetate

Substances

  • Antineoplastic Agents
  • Medroxyprogesterone Acetate
  • Medroxyprogesterone